{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:08:07Z","timestamp":1774123687516,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41443-018-0099-2","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T16:09:18Z","timestamp":1551802158000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Sildenafil\/Viagra in the treatment of premature ejaculation"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-9218","authenticated-orcid":false,"given":"Pramod","family":"Krishnappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esau","family":"Fernandez-Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Carballido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Ignacio","family":"Martinez-Salamanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"99_CR1","unstructured":"20895ltr.pdf [Internet]. Available from: \n                    https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/1998\/20895ltr.pdf\n                    \n                   [cited 2018 Oct 27]"},{"key":"99_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1377\/hlthaff.19.2.147","volume":"19","author":"A Keith","year":"2000","unstructured":"Keith A. The economics of Viagra. Health Aff Proj Hope. 2000;19:147\u201357.","journal-title":"Health Aff Proj Hope"},{"key":"99_CR3","unstructured":"A History of Viagra. Available from: \n                    https:\/\/www.bloomberg.com\/news\/features\/2017-12-11\/the-little-blue-pill-an-oral-history-of-viagra\n                    \n                  ; 2017 Dec 11 [cited 2018 Oct 27]"},{"key":"99_CR4","unstructured":"Pfizer to lose patent of drug Viagra, Indian companies gear up with copycat versions [Internet]. https:\/\/www.hindustantimes.com\/. 2018. Available from: \n                    https:\/\/www.hindustantimes.com\/business-news\/pfizer-to-lose-patent-of-drug-viagra-indian-companies-gear-up-with-copycat-versions\/story-jrBkWfXF1A6fO7insmqmCN.html\n                    \n                   [cited 2018 Sep 21]"},{"key":"99_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/jsm.12524","volume":"11","author":"EC Serefoglu","year":"2014","unstructured":"Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med. 2014;11:1423\u201341.","journal-title":"J Sex Med"},{"issue":"4 Pt 2","key":"99_CR6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/j.1743-6109.2010.01782.x","volume":"7","author":"D Rowland","year":"2010","unstructured":"Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(4 Pt 2):1668\u201386.","journal-title":"J Sex Med"},{"key":"99_CR7","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1523\/JNEUROSCI.15-11-07465.1995","volume":"15","author":"EM Hull","year":"1995","unstructured":"Hull EM, Du J, Lorrain DS, Matuszewich L. Extracellular dopamine in the medial preoptic area: implications for sexual motivation and hormonal control of copulation. J Neurosci. 1995;15:7465\u201371.","journal-title":"J Neurosci"},{"issue":"Suppl. 4","key":"99_CR8","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.1111\/j.1743-6109.2006.00305.x","volume":"3","author":"CF Donatucci","year":"2006","unstructured":"Donatucci CF. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med. 2006;3(Suppl. 4):S303\u2013S8.","journal-title":"J Sex Med"},{"key":"99_CR9","doi-asserted-by":"publisher","first-page":"R269","DOI":"10.1152\/ajpregu.2001.281.1.R269","volume":"281","author":"Y Sato","year":"2001","unstructured":"Sato Y, Zhao W, Christ GJ. Central modulation of the NO\/cGMP pathway affects the MPOA-induced intracavernous pressure response. Am J Physiol Regul Integr Comp Physiol. 2001;281:R269\u2013278.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"99_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1464-410X.1995.tb00763.x","volume":"76","author":"JS Dixon","year":"1995","unstructured":"Dixon JS, Jen PY. Development of nerves containing nitric oxide synthase in the human male urogenital organs. Br J Urol. 1995;76:719\u201325.","journal-title":"Br J Urol"},{"key":"99_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.eururo.2007.08.005","volume":"52","author":"J Chen","year":"2007","unstructured":"Chen J, Keren-Paz G, Bar-Yosef Y, Matzkin H. The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data. Eur Urol. 2007;52:1331\u20139.","journal-title":"Eur Urol"},{"key":"99_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1517\/14728220802663549","volume":"13","author":"IA Abdel-Hamid","year":"2009","unstructured":"Abdel-Hamid IA, Jannini EA, Andersson K-E. Premature ejaculation: focus on therapeutic targets. Expert Opin Ther Targets. 2009;13:175\u201393.","journal-title":"Expert Opin Ther Targets"},{"key":"99_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1743-6109.2008.01085.x","volume":"6","author":"S Uckert","year":"2009","unstructured":"Uckert S, Bazrafshan S, Sonnenberg JE, Kuczyk MA. Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulation. J Sex Med. 2009;6:408\u201314.","journal-title":"J Sex Med"},{"key":"99_CR14","doi-asserted-by":"crossref","unstructured":"Birowo P, Uckert S, Kedia GT, Sonnenberg JE, Sandner P, Thon WF, et al. Exposure of human seminal vesicle tissue to phosphodiesterase (PDE) inhibitors antagonizes the contraction induced by norepinephrine and increases production of cyclic nucleotides. Urology 2010;76:1518.e1-6.","DOI":"10.1016\/j.urology.2010.07.461"},{"key":"99_CR15","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/S0022-5347(06)00280-1","volume":"175","author":"I Orhan","year":"2006","unstructured":"Orhan I, Onur R, Ta\u015fdemir C, Ayar A, Kadio\u011flu A. Sildenafil citrate inhibits agonist induced contractions in isolated rat seminal vesicles. J Urol. 2006;175:2350\u20133.","journal-title":"J Urol"},{"key":"99_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","volume":"2","author":"CG McMahon","year":"2005","unstructured":"McMahon CG, Stuckey BGA, Andersen M, Purvis K, Koppiker N, Haughie S, et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med. 2005;2:368\u201375.","journal-title":"J Sex Med"},{"key":"99_CR17","unstructured":"ISSM-Quick-Reference-Guide-to-PE.pdf [Internet]. Available from: \n                    https:\/\/professionals.issm.info\/wp-content\/uploads\/sites\/2\/2018\/05\/ISSM-Quick-Reference-Guide-to-PE.pdf\n                    \n                   [cited 2018 Sep 21]"},{"key":"99_CR18","unstructured":"Hatzimouratidis K, Eardley I, Giuliano F, Moncada I, Salonia A. Male sexual dysfunction [Internet]. Uroweb. Available from: \n                    http:\/\/uroweb.org\/guideline\/male-sexual-dysfunction\/\n                    \n                   [cited 2018 Sep 21]."},{"key":"99_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/smrj.49","volume":"3","author":"CG McMahon","year":"2015","unstructured":"McMahon CG. Current and emerging treatments for premature ejaculation. Sex Med Rev. 2015;3:183\u2013202.","journal-title":"Sex Med Rev"},{"key":"99_CR20","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/PPA.S110632","volume":"10","author":"C Cartwright","year":"2016","unstructured":"Cartwright C, Gibson K, Read J, Cowan O, Dehar T. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence. 2016;10:1401\u20137.","journal-title":"Patient Prefer Adherence"},{"key":"99_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/01.ju.0000132159.61156.ea","volume":"172","author":"DK Montague","year":"2004","unstructured":"Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JPW, Lue TF, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol. 2004;172:290\u20134.","journal-title":"J Urol"},{"key":"99_CR22","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1111\/j.1743-6109.2011.02401.x","volume":"8","author":"EA Jannini","year":"2011","unstructured":"Jannini EA, McMahon C, Chen J, Aversa A, Perelman M. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med. 2011;8:2135\u201343.","journal-title":"J Sex Med"},{"key":"99_CR23","first-page":"331","volume":"14","author":"WF Wang","year":"2007","unstructured":"Wang W-F, Wang Y, Minhas S, Ralph DJ. Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol J Jpn Urol Assoc. 2007;14:331\u20135.","journal-title":"Int J Urol J Jpn Urol Assoc"},{"key":"99_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.aju.2013.05.003","volume":"11","author":"TA Gameel","year":"2013","unstructured":"Gameel TA, Tawfik AM, Abou-Farha MO, Bastawisy MG, El-Bendary MA, El-Gamasy AE-N. On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: a randomised placebo-controlled clinical trial. Arab J Urol. 2013;11:392\u20137.","journal-title":"Arab J Urol"},{"key":"99_CR25","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1464-410X.2010.09646.x","volume":"107","author":"A G\u00f6k\u00e7e","year":"2011","unstructured":"G\u00f6k\u00e7e A, Halis F, Demirtas A, Ekmekcioglu O. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study. BJU Int. 2011;107:1274\u20137.","journal-title":"BJU Int"},{"key":"99_CR26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1743-6109.2012.02972.x","volume":"10","author":"O Shaeer","year":"2013","unstructured":"Shaeer O. The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers. J Sex Med. 2013;10:532\u201340.","journal-title":"J Sex Med"},{"key":"99_CR27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/and.12540","volume":"48","author":"C Men","year":"2016","unstructured":"Men C, Yu L, Yuan H, Cui Y. Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and meta-analysis. Andrologia. 2016;48:978\u201385.","journal-title":"Andrologia"},{"key":"99_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.urology.2015.06.045","volume":"86","author":"Y Bai","year":"2015","unstructured":"Bai Y, Pu C, Han P, Li J, Yuan H, Tang Y, et al. Selective serotonin reuptake inhibitors plus phosphodiesterase-5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Urology. 2015;86:758\u201364.","journal-title":"Urology"},{"key":"99_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.urology.2015.06.051","volume":"86","author":"Y Sun","year":"2015","unstructured":"Sun Y, Luo D, Yang L, Tang C, Yang T, Hu X, et al. Efficacy of phosphodiesterase-5 inhibitor in men with premature ejaculation: a new systematic review and meta-analysis. Urology. 2015;86:947\u201354.","journal-title":"Urology"},{"key":"99_CR30","doi-asserted-by":"crossref","unstructured":"Abu El-Hamd M, Abdelhamed A. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Andrologia. 2018;50.","DOI":"10.1111\/and.12829"},{"key":"99_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.euf.2016.02.001","volume":"3","author":"M Martyn-St James","year":"2017","unstructured":"Martyn-St James M, Cooper K, Ren S, Kaltenthaler E, Dickinson K, Cantrell A, et al. Phosphodiesterase Type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Eur Urol Focus. 2017;3:119\u201329.","journal-title":"Eur Urol Focus"},{"key":"99_CR32","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.urology.2009.04.026","volume":"74","author":"A Tsertsvadze","year":"2009","unstructured":"Tsertsvadze A, Yazdi F, Fink HA, MacDonald R, Wilt TJ, Bella AJ, et al. Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and meta-analysis of harms. Urology. 2009;74:831\u2013836.e8.","journal-title":"Urology"},{"key":"99_CR33","first-page":"975","volume":"3","author":"JG McMurray","year":"2007","unstructured":"McMurray JG, Feldman RA, Auerbach SM, DeRiesthal H, Wilson N. Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction. Ther Clin Risk Manag. 2007;3:975\u201381.","journal-title":"Ther Clin Risk Manag"},{"key":"99_CR34","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/S0022-5347(01)63299-3","volume":"159","author":"SA Ballard","year":"1998","unstructured":"Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol. 1998;159:2164\u201371.","journal-title":"J Urol"},{"key":"99_CR35","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.2147\/DDDT.S118015","volume":"8","author":"MM Moschos","year":"2016","unstructured":"Moschos MM, Nitoda E. Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction. Drug Des Devel Ther. 2016;8:3407\u201313.","journal-title":"Drug Des Devel Ther"},{"key":"99_CR36","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1136\/bmj.e554","volume":"344","author":"BM Wirostko","year":"2012","unstructured":"Wirostko BM, Tressler C, Hwang L-J, Burgess G, Laties AM. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension. Br Med J. 2012;344:e554.","journal-title":"Br Med J"},{"key":"99_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1743-6109.2005.00194.x","volume":"3","author":"A Laties","year":"2006","unstructured":"Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med. 2006;3:12\u201327.","journal-title":"J Sex Med"},{"key":"99_CR38","unstructured":"Pentyala S, Rahman A, Mishra S, Muthiki S, Hughes E, Bikkani A, et al. Pharmacokinetic drug interactions of phosphodiesterase-5 inhibitors mediated by cytochrome P450 3A4 isoform. 10."},{"key":"99_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1743-6109.2011.02338.x","volume":"9","author":"O Shaeer","year":"2012","unstructured":"Shaeer O, Shaeer K. The Global Online Sexuality Survey (GOSS): ejaculatory function, penile anatomy, and contraceptive usage among Arabic-speaking Internet users in the Middle East. J Sex Med. 2012;9:425\u201333.","journal-title":"J Sex Med"},{"key":"99_CR40","doi-asserted-by":"crossref","unstructured":"Shaeer O, Shaeer K, Serefoglu EC, Fode M. 381 Premature ejaculation among english-speaking male internet users in the USA: Results From the Global Online Sexuality Survey (GOSS) 2015. J Sex Med. 2017 (1):S112\u20133.","DOI":"10.1016\/j.jsxm.2016.11.262"},{"key":"99_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","volume":"98","author":"CG McMahon","year":"2006","unstructured":"McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int. 2006;98:259\u201372.","journal-title":"BJU Int"},{"key":"99_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jsxm.2016.08.016","volume":"14","author":"WA Fisher","year":"2017","unstructured":"Fisher WA, Gruenwald I, Jannini EA, Lev-Sagie A, Lowenstein L, Pyke RE, et al. Standards for Clinical Trials in Male and Female Sexual Dysfunction: III. Unique Aspects of Clinical Trials in Male Sexual Dysfunction. J Sex Med. 2017;14:3\u201318.","journal-title":"J Sex Med"},{"key":"99_CR43","unstructured":"Tang W, Ma L, Zhao L, Liu Y. Efficacy and safety of Sertraline, Viagra and Cardura in patients with premature ejaculation [Internet]; 2014. Available from: \n                    http:\/\/en.cnki.com.cn\/Article_en\/CJFDTOTAL-NXXX200406007.htm\n                    \n                  . [cited 2018 Sep 21]"},{"key":"99_CR44","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S0090-4295(99)00187-9","volume":"54","author":"SW Kim","year":"1999","unstructured":"Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology. 1999;54:544\u20137.","journal-title":"Urology"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0099-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0099-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0099-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:28:42Z","timestamp":1684618122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0099-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0099-2","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"23 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}